Clearance Summary
MyOnyx System received FDA 510(k) clearance under submission number K213197, sponsored by Thought Technology , Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Physical Medicine review panel. The statutory decision date of record is 2022-06-17.
- Submission: K213197
- Applicant / Sponsor: Thought Technology , Ltd.
- Clearance pathway: Traditional
- Review panel: Physical Medicine
- Device class: Class II
- Regulation citation: 21 CFR 890.5850
- Decision date: 2022-06-17
Classification & Regulation
This clearance is catalogued under FDA product code IPF and 21 CFR 890.5850, within the Physical Medicine review panel as a Class II device.